Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of February 28, 2026, Beam Therapeutics Inc. (BEAM) has a Wall Street consensus price target of $40.86, based on estimates from 27 covering analysts. With the stock currently trading at $28.46, this represents a potential upside of +43.6%. The company has a market capitalization of $2.90B.
Analyst price targets range from a low of $26.00 to a high of $74.00, representing a 117% spread in expectations. The median target of $41.00 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 18 analysts rating the stock as a Buy or Strong Buy,8 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, BEAM trades at a trailing P/E of -35.1x. Analysts expect EPS to grow -464.8% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how BEAM stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonThe consensus Wall Street price target for BEAM is $40.86, representing 43.6% upside from the current price of $28.46. With 27 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
BEAM has a consensus rating of "Buy" based on 27 Wall Street analysts. The rating breakdown is predominantly bullish, with 18 Buy/Strong Buy ratings. The consensus 12-month price target of $40.86 implies 43.6% upside from current levels.
BEAM's current price is $28.46 with a consensus target of $40.86 (43.6% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $74 for BEAM, while the most conservative target is $26. The consensus of $40.86 represents the median expectation. These targets typically reflect 12-month expectations.
BEAM is heavily covered by Wall Street, with 27 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 18 have Buy ratings, 8 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month BEAM stock forecast based on 27 Wall Street analysts shows a consensus price target of $40.86, with estimates ranging from $26 (bear case) to $74 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on BEAM, with a "Buy" consensus rating and $40.86 price target (43.6% upside). 18 of 27 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
BEAM analyst price targets range from $26 to $74, a 117% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $40.86 consensus represents the middle ground.